T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
Author:
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Link
https://www.nature.com/articles/s41423-022-00838-5.pdf
Reference9 articles.
1. Liu L, Iketani S, Guo Y, Chan JFW, Wang M, Liu L, et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2021. https://doi.org/10.1038/d41586-021-03826-3.
2. Planas D, Saunders N, Schwartz O Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2021. https://doi.org/10.1038/d41586-021-03827-2.
3. Cele S, Jackson L, Sigal A Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. 2021. https://doi.org/10.1038/d41586-021-03824-5.
4. Tarke A, Sidney J, Kidd CK, Dan JM, Ramirez SI, Yu ED, et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep Med. 2021;2:100204 https://doi.org/10.1016/j.xcrm.2021.100204.
5. Saini SK, Hersby DS, Tamhane T, Povlsen HR, Hernandez SPA, Nielsen M, et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. Sci Immunol. 2021;6:eabf7550 https://doi.org/10.1126/sciimmunol.abf7550.
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates;Nature Immunology;2024-09-03
2. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09
3. Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2;Nature Communications;2024-08-27
4. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways;Nature Communications;2024-08-12
5. Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2;Acta Biomaterialia;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3